Mylotarg听is a drug-linked听monoclonal antibody听(an听antibody-drug conjugate) that was used to treat听acute myeloid leukemia听from 2000 to 2010.
The global market for Mylotarg was estimated to be worth US$ 214.3 million in 2023 and is forecast to a readjusted size of US$ 179.5 million by 2030 with a CAGR of -2.5% during the forecast period 2024-2030
Gemtuzumab Ozogamicin is an antibody-drug conjugate used to treat certain types of acute myeloid leukemia (AML). Its efficacy in targeting CD33-expressing AML cells and inducing remission has driven market growth. The limited treatment options for CD33-positive AML contribute to its niche status. However, challenges include potential side effects and the need for careful patient selection. The market competition is relatively small, as Gemtuzumab Ozogamicin remains a targeted therapy for a specific AML subgroup. Despite challenges, the Gemtuzumab Ozogamicin market offers potential for growth as healthcare providers seek effective treatments for patients with CD33-positive AML. Continued research and clinical advancements can further drive market expansion.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Mylotarg, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Mylotarg by region & country, by Type, and by Application.
The Mylotarg market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mylotarg.
麻豆原创 Segmentation
By Company
Pfizer
Segment by Type:
5mg/Vial
4.5mg/Vial
Segment by Application
Hospital
Pharmacy
By Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Mylotarg manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Mylotarg in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Mylotarg in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 麻豆原创 Overview
1.1 Mylotarg Product Introduction
1.2 Global Mylotarg 麻豆原创 Size Forecast
1.2.1 Global Mylotarg Sales Value (2019-2030)
1.2.2 Global Mylotarg Sales Volume (2019-2030)
1.2.3 Global Mylotarg Sales Price (2019-2030)
1.3 Mylotarg 麻豆原创 Trends & Drivers
1.3.1 Mylotarg Industry Trends
1.3.2 Mylotarg 麻豆原创 Drivers & Opportunity
1.3.3 Mylotarg 麻豆原创 Challenges
1.3.4 Mylotarg 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Mylotarg Players Revenue Ranking (2023)
2.2 Global Mylotarg Revenue by Company (2019-2024)
2.3 Global Mylotarg Players Sales Volume Ranking (2023)
2.4 Global Mylotarg Sales Volume by Company Players (2019-2024)
2.5 Global Mylotarg Average Price by Company (2019-2024)
2.6 Key Manufacturers Mylotarg Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Mylotarg Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Mylotarg
2.9 Mylotarg 麻豆原创 Competitive Analysis
2.9.1 Mylotarg 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Mylotarg Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mylotarg as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 5mg/Vial
3.1.2 4.5mg/Vial
3.2 Global Mylotarg Sales Value by Type
3.2.1 Global Mylotarg Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Mylotarg Sales Value, by Type (2019-2030)
3.2.3 Global Mylotarg Sales Value, by Type (%) (2019-2030)
3.3 Global Mylotarg Sales Volume by Type
3.3.1 Global Mylotarg Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Mylotarg Sales Volume, by Type (2019-2030)
3.3.3 Global Mylotarg Sales Volume, by Type (%) (2019-2030)
3.4 Global Mylotarg Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Pharmacy
4.2 Global Mylotarg Sales Value by Application
4.2.1 Global Mylotarg Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Mylotarg Sales Value, by Application (2019-2030)
4.2.3 Global Mylotarg Sales Value, by Application (%) (2019-2030)
4.3 Global Mylotarg Sales Volume by Application
4.3.1 Global Mylotarg Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Mylotarg Sales Volume, by Application (2019-2030)
4.3.3 Global Mylotarg Sales Volume, by Application (%) (2019-2030)
4.4 Global Mylotarg Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Mylotarg Sales Value by Region
5.1.1 Global Mylotarg Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Mylotarg Sales Value by Region (2019-2024)
5.1.3 Global Mylotarg Sales Value by Region (2025-2030)
5.1.4 Global Mylotarg Sales Value by Region (%), (2019-2030)
5.2 Global Mylotarg Sales Volume by Region
5.2.1 Global Mylotarg Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Mylotarg Sales Volume by Region (2019-2024)
5.2.3 Global Mylotarg Sales Volume by Region (2025-2030)
5.2.4 Global Mylotarg Sales Volume by Region (%), (2019-2030)
5.3 Global Mylotarg Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Mylotarg Sales Value, 2019-2030
5.4.2 North America Mylotarg Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Mylotarg Sales Value, 2019-2030
5.5.2 Europe Mylotarg Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Mylotarg Sales Value, 2019-2030
5.6.2 Asia Pacific Mylotarg Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Mylotarg Sales Value, 2019-2030
5.7.2 South America Mylotarg Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Mylotarg Sales Value, 2019-2030
5.8.2 Middle East & Africa Mylotarg Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Mylotarg Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Mylotarg Sales Value
6.2.1 Key Countries/Regions Mylotarg Sales Value, 2019-2030
6.2.2 Key Countries/Regions Mylotarg Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Mylotarg Sales Value, 2019-2030
6.3.2 United States Mylotarg Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Mylotarg Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Mylotarg Sales Value, 2019-2030
6.4.2 Europe Mylotarg Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Mylotarg Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Mylotarg Sales Value, 2019-2030
6.5.2 China Mylotarg Sales Value by Type (%), 2023 VS 2030
6.5.3 China Mylotarg Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Mylotarg Sales Value, 2019-2030
6.6.2 Japan Mylotarg Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Mylotarg Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Mylotarg Sales Value, 2019-2030
6.7.2 South Korea Mylotarg Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Mylotarg Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Mylotarg Sales Value, 2019-2030
6.8.2 Southeast Asia Mylotarg Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Mylotarg Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Mylotarg Sales Value, 2019-2030
6.9.2 India Mylotarg Sales Value by Type (%), 2023 VS 2030
6.9.3 India Mylotarg Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Company Information
7.1.2 Pfizer Introduction and Business Overview
7.1.3 Pfizer Mylotarg Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Pfizer Mylotarg Product Offerings
7.1.5 Pfizer Recent Development
8 Industry Chain Analysis
8.1 Mylotarg Industrial Chain
8.2 Mylotarg Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Mylotarg Sales Model
8.5.2 Sales Channel
8.5.3 Mylotarg Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Pfizer
听
听
*If Applicable.